[go: up one dir, main page]

GB201106981D0 - Compounds for the treatment of clostridium difficle-associated disease - Google Patents

Compounds for the treatment of clostridium difficle-associated disease

Info

Publication number
GB201106981D0
GB201106981D0 GBGB1106981.2A GB201106981A GB201106981D0 GB 201106981 D0 GB201106981 D0 GB 201106981D0 GB 201106981 A GB201106981 A GB 201106981A GB 201106981 D0 GB201106981 D0 GB 201106981D0
Authority
GB
United Kingdom
Prior art keywords
compounds
treatment
associated disease
clostridium difficle
difficle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1106981.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Summit Therapeutics Ltd
Original Assignee
Summit Corp PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Summit Corp PLC filed Critical Summit Corp PLC
Priority to GBGB1106981.2A priority Critical patent/GB201106981D0/en
Priority to CN201180037073.2A priority patent/CN103025383B/en
Priority to HK13104684.8A priority patent/HK1177706B/en
Priority to EP11728027.1A priority patent/EP2575968B1/en
Priority to PL11728027T priority patent/PL2575968T3/en
Priority to BR112012030621-9A priority patent/BR112012030621B1/en
Priority to RU2012157571/04A priority patent/RU2575477C2/en
Priority to HUE11728027A priority patent/HUE028746T2/en
Priority to JP2013512984A priority patent/JP5845502B2/en
Priority to ES15190275T priority patent/ES2803556T3/en
Priority to CA2801274A priority patent/CA2801274C/en
Priority to EP15190275.6A priority patent/EP3011960B1/en
Priority to ES11728027.1T priority patent/ES2568455T3/en
Priority to SI201130790A priority patent/SI2575968T1/en
Priority to PT117280271T priority patent/PT2575968E/en
Priority to DK11728027.1T priority patent/DK2575968T3/en
Priority to AU2011260097A priority patent/AU2011260097B2/en
Priority to RS20160310A priority patent/RS54781B1/en
Priority to PCT/GB2011/000831 priority patent/WO2011151621A1/en
Priority to HRP20160397TT priority patent/HRP20160397T1/en
Publication of GB201106981D0 publication Critical patent/GB201106981D0/en
Priority to US13/691,319 priority patent/US8987308B2/en
Priority to HK16111340.6A priority patent/HK1223032A1/en
Priority to US14/620,902 priority patent/US9278091B2/en
Priority to JP2015090826A priority patent/JP6150841B2/en
Priority to US15/011,185 priority patent/US20170217983A2/en
Priority to CY20161100379T priority patent/CY1117671T1/en
Priority to SM201600260T priority patent/SMT201600260B/en
Ceased legal-status Critical Current

Links

GBGB1106981.2A 2010-06-01 2011-04-27 Compounds for the treatment of clostridium difficle-associated disease Ceased GB201106981D0 (en)

Priority Applications (27)

Application Number Priority Date Filing Date Title
GBGB1106981.2A GB201106981D0 (en) 2011-04-27 2011-04-27 Compounds for the treatment of clostridium difficle-associated disease
PT117280271T PT2575968E (en) 2010-06-01 2011-06-01 Compounds for the treatment of clostridium difficile associated disease
SI201130790A SI2575968T1 (en) 2010-06-01 2011-06-01 Compounds for the treatment of clostridium difficile associated disease
EP11728027.1A EP2575968B1 (en) 2010-06-01 2011-06-01 Compounds for the treatment of clostridium difficile associated disease
PL11728027T PL2575968T3 (en) 2010-06-01 2011-06-01 Compounds for the treatment of clostridium difficile associated disease
DK11728027.1T DK2575968T3 (en) 2010-06-01 2011-06-01 COMPOUNDS FOR THE TREATMENT OF Clostridium difficile-associated disease
RU2012157571/04A RU2575477C2 (en) 2010-06-01 2011-06-01 Compounds for treating clostridium difficile associated diseases
HUE11728027A HUE028746T2 (en) 2010-06-01 2011-06-01 Compounds for the treatment of clostridium difficile associated disease
JP2013512984A JP5845502B2 (en) 2010-06-01 2011-06-01 Compounds for treating Clostridium difficile-related diseases
ES15190275T ES2803556T3 (en) 2010-06-01 2011-06-01 Compounds for the treatment of diseases associated with clostridium difficile
HK13104684.8A HK1177706B (en) 2010-06-01 2011-06-01 Compounds for the treatment of clostridium difficile associated disease
EP15190275.6A EP3011960B1 (en) 2010-06-01 2011-06-01 Compounds for the treatment of clostridium difficile-associated disease
ES11728027.1T ES2568455T3 (en) 2010-06-01 2011-06-01 Compounds for the treatment of Clostridium difficile-associated disease
CN201180037073.2A CN103025383B (en) 2010-06-01 2011-06-01 Compounds for the treatment of diseases associated with Clostridium difficile
CA2801274A CA2801274C (en) 2010-06-01 2011-06-01 Compounds for the treatment of clostridium difficile-associated disease
BR112012030621-9A BR112012030621B1 (en) 2010-06-01 2011-06-01 compounds for the treatment of disease associated with clostridium difficile
AU2011260097A AU2011260097B2 (en) 2010-06-01 2011-06-01 Compounds for the treatment of clostridium difficile associated disease
RS20160310A RS54781B1 (en) 2010-06-01 2011-06-01 CLOSTRIDIUM DIFFICILE DISEASE UNITS
PCT/GB2011/000831 WO2011151621A1 (en) 2010-06-01 2011-06-01 Compounds for the treatment of clostridium difficile associated disease
HRP20160397TT HRP20160397T1 (en) 2010-06-01 2011-06-01 Compounds for the treatment of clostridium difficile associated disease
US13/691,319 US8987308B2 (en) 2010-06-01 2012-11-30 Compounds for the treatment of Clostridium difficile-associated disease
HK16111340.6A HK1223032A1 (en) 2010-06-01 2013-04-17 Compounds for the treatment of clostridium difficile associated disease
US14/620,902 US9278091B2 (en) 2010-06-01 2015-02-12 Compounds for the treatment of Clostridium difficile associated disease
JP2015090826A JP6150841B2 (en) 2010-06-01 2015-04-27 Compounds for treating Clostridium difficile-related diseases
US15/011,185 US20170217983A2 (en) 2010-06-01 2016-01-29 Compounds for the treatment of clostridium difficile associated disease
CY20161100379T CY1117671T1 (en) 2010-06-01 2016-05-06 CLOSTRIDIUM DIFFICILE COMPLICATIONS FOR THERAPEUTIC DISEASE TREATMENT
SM201600260T SMT201600260B (en) 2010-06-01 2016-08-03 COMPOUNDS FOR TREATING A DISEASE ASSOCIATED WITH A DIFFICULT CLOSTRIDIUM

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1106981.2A GB201106981D0 (en) 2011-04-27 2011-04-27 Compounds for the treatment of clostridium difficle-associated disease

Publications (1)

Publication Number Publication Date
GB201106981D0 true GB201106981D0 (en) 2011-06-08

Family

ID=44168569

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1106981.2A Ceased GB201106981D0 (en) 2010-06-01 2011-04-27 Compounds for the treatment of clostridium difficle-associated disease

Country Status (1)

Country Link
GB (1) GB201106981D0 (en)

Similar Documents

Publication Publication Date Title
ZA201403795B (en) Formulations for the treatment of diabetes
AP3544A (en) Compounds for the treatment of addiction
ZA201402424B (en) 1- arylcarbonyl -4 - oxy - piperidine compounds useful for the treatment of neurodegenerative diseases
PL2575968T3 (en) Compounds for the treatment of clostridium difficile associated disease
IL234796B (en) Compounds for the treatment of ischemia-reperfusion-related diseases
GB201013060D0 (en) Compounds for the treatment of clostridium difficile associated disease
GB201013058D0 (en) Compounds for the treatment of clostridium difficile associated disease
GB201009108D0 (en) Compounds for the treatment of clostridium difficile associated disease
GB201009090D0 (en) Compounds for the treatment of clostridium difficile associated disease
GB201009085D0 (en) Compounds for the treatment of clostridium difficile associated disease
GB201009091D0 (en) Compounds for the treatment of clostridium difficile-associated disease
GB201106981D0 (en) Compounds for the treatment of clostridium difficle-associated disease
GB201106970D0 (en) Compounds for the treatment of clostridium difficile-associated disease
GB201106972D0 (en) Compounds for the treatment of clostridium difficile-associated disease
GB201106968D0 (en) Compounds for the treatment of clostridium difficile associated disease
GB201106985D0 (en) Compounds for the treatment of clostridium difficile associated disease
GB201009081D0 (en) Compounds for the treatment of clostridium difficile associated disease
GB201009104D0 (en) Compounds for the treatment of clostridium difficile associated disease
IL232294B (en) Formulations for the treatment of diabetes
GB201009097D0 (en) Compounds for the treatment of clostridium difficile-associated disease
GB201009095D0 (en) Compounds for the treatment of clostridium difficile-associated disease
GB201119533D0 (en) Compounds for the treatment of neoplasia
GB201009094D0 (en) Compounds for the treatment of closridium difficile-associated disease
GB201108301D0 (en) IVlg treatment for patients with Myeloma

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)